Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Tindall

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|September 30, 2005
Microsomal prediction of in vivo clearance and associated interindividual variability of six benzodiazepines in humansH C Rawden, D J Carlile, A Tindall, et al.
Disability and Rehabilitation|June 20, 2007
Club foot treatment in Malawi - a public health approachC B D Lavy, S J Mannion, N C Mkandawire, et al.
Adipocyte|April 19, 2021
Cleavage of the vaspin N-terminus releases cell-penetrating peptides that affect early stages of adipogenesis and inhibit lipolysis in mature adipocytesCatherine A Tindall, Estelle Erkner, Jan Stichel, et al.
Journal of Medicinal Chemistry|May 7, 2020
Structural Studies on the Inhibitory Binding Mode of Aromatic Coumarinic Esters to Human Kallikrein-Related Peptidase 7Stefanie Hanke, Catherine A Tindall, Jan Pippel, et al.
Plos One|December 20, 2012
A novel SERPINA1 mutation causing serum alpha(1)-antitrypsin deficiencyDarren N Saunders, Elizabeth A Tindall, Robert F Shearer, et al.
Contemporary Clinical Trials Communications|August 22, 2019
Rationale and design of a pilot study to evaluate the acceptability and effectiveness of a revised protein sparing modified fast (rPSMF) for severe obesity in a pediatric tertiary care weight management clinicI U Eneli, R P Watowicz, J Xu, et al.
Clinical Therapeutics|February 13, 2003
A 12-month, multicenter, prospective, open-label trial of radiographic analysis of disease progression in osteoarthritis of the knee or hip in patients receiving celecoxibElizabeth A Tindall, John T Sharp, Aimee Burr, et al.
Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association|November 26, 2003
Evaluation of health-related quality of life of rheumatoid arthritis patients treated with celecoxibS Z Zhao, J I Fiechtner, E A Tindall, et al.
Annals of Internal Medicine|September 1, 1995
Misoprostol dosage in the prevention of nonsteroidal anti-inflammatory drug-induced gastric and duodenal ulcers: a comparison of three regimensJ B Raskin, R H White, J E Jackson, et al.
BMC Urology|December 31, 2013
Addressing the contribution of previously described genetic and epidemiological risk factors associated with increased prostate cancer risk and aggressive disease within men from South AfricaElizabeth A Tindall, M S Riana Bornman, Smit van Zyl, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|September 30, 2005
Microsomal prediction of in vivo clearance and associated interindividual variability of six benzodiazepines in humansH C Rawden, D J Carlile, A Tindall, et al.
Disability and Rehabilitation|June 20, 2007
Club foot treatment in Malawi - a public health approachC B D Lavy, S J Mannion, N C Mkandawire, et al.
Adipocyte|April 19, 2021
Cleavage of the vaspin N-terminus releases cell-penetrating peptides that affect early stages of adipogenesis and inhibit lipolysis in mature adipocytesCatherine A Tindall, Estelle Erkner, Jan Stichel, et al.
Journal of Medicinal Chemistry|May 7, 2020
Structural Studies on the Inhibitory Binding Mode of Aromatic Coumarinic Esters to Human Kallikrein-Related Peptidase 7Stefanie Hanke, Catherine A Tindall, Jan Pippel, et al.
Plos One|December 20, 2012
A novel SERPINA1 mutation causing serum alpha(1)-antitrypsin deficiencyDarren N Saunders, Elizabeth A Tindall, Robert F Shearer, et al.
Contemporary Clinical Trials Communications|August 22, 2019
Rationale and design of a pilot study to evaluate the acceptability and effectiveness of a revised protein sparing modified fast (rPSMF) for severe obesity in a pediatric tertiary care weight management clinicI U Eneli, R P Watowicz, J Xu, et al.
Clinical Therapeutics|February 13, 2003
A 12-month, multicenter, prospective, open-label trial of radiographic analysis of disease progression in osteoarthritis of the knee or hip in patients receiving celecoxibElizabeth A Tindall, John T Sharp, Aimee Burr, et al.
Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association|November 26, 2003
Evaluation of health-related quality of life of rheumatoid arthritis patients treated with celecoxibS Z Zhao, J I Fiechtner, E A Tindall, et al.
Annals of Internal Medicine|September 1, 1995
Misoprostol dosage in the prevention of nonsteroidal anti-inflammatory drug-induced gastric and duodenal ulcers: a comparison of three regimensJ B Raskin, R H White, J E Jackson, et al.
BMC Urology|December 31, 2013
Addressing the contribution of previously described genetic and epidemiological risk factors associated with increased prostate cancer risk and aggressive disease within men from South AfricaElizabeth A Tindall, M S Riana Bornman, Smit van Zyl, et al.
Pageof 6